Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
GNAS1 T393C Polymorphism Is Associated with Clinical Course in Patients with Intrahepatic Cholangiocarcinoma
2007
Immunosuppression in renal transplantation II. Corticosteroids, antilymphocyte globulin, and OKT3
1991
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
2011
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges
2006 StandoutNobel
Hepatocellular carcinoma
2003 Standout
Utilizing List Exchange and Nondirected Donation through ‘Chain’ Paired Kidney Donations
2006 StandoutNobel
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2016 Standout
Graft-versus-host disease in solid organ transplantation
1991
Ethics of a Paired-Kidney-Exchange Program
1997
Right lobe living donor liver transplantation: A review
2000
Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma
2004
Adult Living Donor Liver Transplantation: the Hepatologist's Perspective
2001
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
Evaluation and stages of surgical innovations
2009 Standout
Liver fibrosis – from bench to bedside
2003 Standout
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATION
1996
Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center
2006
Hepatocellular carcinoma
2012 Standout
Left Lateral Segmentectomy for Pediatric Live-Donor Liver Transplantation: Special Attention to Segment IV Complications
2008
Hepatobiliary surgery
2000
Hepatocellular carcinoma
2021 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation
2004 StandoutNobel
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Aspergillosis in Solid Organ Transplantation
2013
Vascular disorders of the liver # †
2008 Standout
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
High Survival Rates of Kidney Transplants from Spousal and Living Unrelated Donors
1995 Standout
Successful Liver Transplantation from a Living Donor to Her Son
1990
Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
1996
Liver transplantation: Current status and novel approaches to liver replacement
2001
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Toward Current Standards of Donor Right Hepatectomy for Adult-to-Adult Live Donor Liver Transplantation Through the Experience of 200 Cases
2006
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Tissue engineering: a 21st century solution to surgical reconstruction
2001
ROLE OF HYPOMAGNESEMIA IN CHRONIC CYCLOSPORINE NEPHROPATHY1
2002 StandoutNobel
Venous complications after orthotopic liver transplantation
2000
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1
1993
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Live Donor Liver Transplantation in Adults
2006
Treatment of Hepatic Venous Outflow Obstruction after Piggyback Liver Transplantation
2005
Hepatocellular Carcinoma
2011
In Vitro Systems for Tissue Engineering
2002
Donor evaluation and hepatectomy for living-donor liver transplantation
2008
Liver Transplantation
1989
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
1998 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Collagen gel systems for sustained delivery and tissue engineering
2003 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Transplantation of Liver Grafts from Living Donors into Adults — Too Much, Too Soon
2001
Historical perspective of living donor liver transplantation
2008
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Infection in Organ-Transplant Recipients
1998 Standout
3D deeply supervised network for automated segmentation of volumetric medical images
2017
Orthotopic liver transplantation in combination with neoadjuvant therapy
2012
Hepatocellular carcinoma
2022 Standout
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
2002 StandoutNobel
Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population
2008
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Infections in solid-organ transplant recipients
1997
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Operations for Intrahepatic Cholangiocarcinoma: Single-Institution Experience of 158 Patients
2009
Preoperative Neutrophil‐to‐Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma
2008
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
1994 Standout
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
1996
Kidney Exchange
2004 StandoutNobel
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity
1995
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
What Have We Learned from Market Design?
2008 StandoutNobel
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Kidney paired donation
2011 StandoutNobel
Current trends in live liver donation
2006
Aspergillus fumigatusand Aspergillosis
1999 Standout
A Kidney Exchange Clearinghouse in New England
2005 StandoutNobel
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation
1993
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
UNet++: Redesigning Skip Connections to Exploit Multiscale Features in Image Segmentation
2019 Standout
Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study
2011
The living donor—risks, benefits and related concerns
1993
Works of C. E. Broelsch being referenced
Living related liver transplantation: 36 cases at the University of Hamburg.
1994
Liver splitting and living donor techniques
1997
Living Donor Liver Transplantation for Hepatocellular Carcinoma in Patients Exceeding the UCSF Criteria
2008
Living-donor liver transplantation in adults
1999
Seropositivity in Liver Transplant Recipients as a Predictor of Cytomegalovirus Disease
1988
Ethics of Liver Transplantation with Living Donors
1989
Formation of Spheroidal Aggregates of Hepatocytes on Biodegradable Polymers Under Continuous-Flow Bioreactor Conditions*
1998
Present and future challenges in living related liver transplantation
1999
Chirurgische Therapie des intrahepatischen cholangiozellulären Karzinoms
2005
Die Bedeutung der arteriellen Gefäßversorgung von Segment IV bei der Leberlebendspende
1997
Application of Reduced-size Liver Transplants as Split Grafts, Auxiliary Orthotopic Grafts, and Living Related Segmental Transplants
1990
Liver Transplantation as a Primary Indication for Intrahepatic Cholangiocarcinoma: A Single-Center Experience
2008
Safety Profile of Concomitant Use of Caspofungin and Cyclosporine or Tacrolimus in Liver Transplant Patients
2006
The successful management of portal vein thrombosis after hepatic transplantation with a splenorenal shunt.
1988
OKT3 TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTION
1987
Liver transplantation from living donors
1994
Computer‐Assisted Operative Planning in Adult Living Donor Liver Transplantation: A New Way to Resolve the Dilemma of the Middle Hepatic Vein
2006
Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis
2004
The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
1991
Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation.
1988
Evolution and future perspectives for reduced-size hepatic transplantation.
1990